[ad_1]
Dublin, December 13, 2021 (Global News Agency) – “2021 Cell-based Testing Global Market Report: COVID-19 Growth and Changes to 2030” Report has been added to ResearchAndMarkets.com supply.
The global cell-based testing market is expected to grow from USD 17.49 billion in 2020 to USD 19.29 billion in 2021, with a compound annual growth rate (CAGR) of 10.3%. It is estimated that by 2025, the market will reach USD 26.69 billion with a compound annual growth rate of 8.5%.
The main players in the cell-based testing market are Thermo Fisher, Danaher, Becton, Dickinson and Company, GE Healthcare, and Merck.
The cell-based test market includes the sale of cell-based tests. Cell-based assays are analytical tools designed to study cell function mechanisms or processes. Companies that develop cell-based assays provide consumables, such as reagents, test kits, and microplates, as well as instruments, services, and software. The report includes the sales of reagents, cell lines, microplates, microplates, detection kits, probes and labels.
The high cost of the instrument is the main factor restricting the global cell-based detection market. Due to the low adaptability, the high price of the instrument will reduce the return on investment (ROI). For example, Biotek has developed HCA (High Content Analysis) instruments, which are expensive and designed for industrial end users or core laboratories with sufficient capital budgets. This restricts end users with lower budgets from fully realizing the potential of cell testing, thus hindering market growth.
Research on cell-based arrays has increased with evolution…
The full story can be found on Benzinga.com
[ad_2]
Source link
